- Home
- GILT vs IMTX Comparison
GILT vs IMTX Comparison
Compare GILT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GILT | IMTX |
|---|---|---|
| Founded | 1987 | N/A |
| Country | Israel | Germany |
| Employees | N/A | 423 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.4B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | GILT | IMTX |
|---|---|---|
| Price | $16.07 | $9.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $20.00 | $19.25 |
| AVG Volume (30 Days) | ★ 1.1M | 356.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.06 | N/A |
| Revenue Next Year | $11.72 | $27.52 |
| P/E Ratio | $42.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.30 | $3.30 |
| 52 Week High | $20.38 | $12.41 |
Technical Indicators
Market Signals| Indicator | GILT | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 48.10 |
| Support Level | $13.11 | $9.66 |
| Resistance Level | $20.38 | $10.64 |
| Average True Range (ATR) | 0.83 | 0.53 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 59.91 | 41.89 |
Price Performance
Historical ComparisonAbout GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.